Rein Therapeutics, Inc. (RNTX) — Net Income

Annual figures by fiscal year, from SEC filings.

2015: -$12.88M2016: -$18.12M2017: -$22.60M2018: -$31.55M2019: -$29.37M2020: -$27.33M2021: -$26.16M2022: -$27.33M2023: -$15.73M2024: -$62.88M2025: -$49.87M-$49.87M
2015Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$49.87M+20.7%
2024-$62.88M-299.7%
2023-$15.73M+42.4%
2022-$27.33M-4.5%
2021-$26.16M+4.3%
2020-$27.33M+6.9%
2019-$29.37M+6.9%
2018-$31.55M-39.6%
2017-$22.60M-24.7%
2016-$18.12M-40.7%
2015-$12.88M